Subsequently, CD8+ T cells may represent the main drivers of the pro-tumor effect, as seen in chronic inflammatory diseases and recently in HCC promoting inflammation in the NTME in an NKG2D-dependent, TCR-independent manner. This evidence concerns the gene KLRK1 and hepatocellular carcinoma.